X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Digital Science launches Dimensions Life Sciences & Chemistry

Content Team by Content Team
26th August 2021
in News
Digital Science launches Dimensions Life Sciences & Chemistry

Digital Science, a technology company with a vision of a trusted and collaborative research ecosystem driving progress for all, is pleased to announce the launch of a new version of its popular Dimensions platform – Dimensions Life Sciences & Chemistry (Dimensions L&C) – focused on life sciences and chemistry research activities.

Dimensions L&C analyzes more than 120 million scientific publications, millions of patents, grants and clinical trial documents. It is both larger than other databases, and unlike traditional manually curated tools, applies up-to-the-minute semantic text analysis tools and ontologies, providing powerful up-to-date discovery functionality previously unavailable at such scale.

In the past, literature search tools required the user to know exactly what they wanted to find, narrowing down the relevant results and confirming or invalidating pre-defined hypotheses. Thanks to insights systematically captured in ontologies and computational power, researchers can get answers to complex and diverse queries directly from the source content.

Users can search for small molecules, chemical reactions and gene sequences, validate biomarkers, understand disease mechanisms and identify drug targets. They can also quickly discover relevant chemical information in broader life sciences and chemistry research areas working with a chemistry structure editor and a biosequence search for nucleotides and proteins. Different from other products, data is identified in full-text documents on a daily basis, creating a highly comprehensive and up-to-date resource.

Digital Science recently announced a collaboration with OntoChem (www.ontochem.com). Dimensions L&C uses the ontologies from OntoChem, which include around 40 million concepts and 100 million synonyms from more than 35 knowledge domains such as compounds, proteins, diseases, drugs, materials, methods, devices or species, enabling a high quality, context sensitive knowledge discovery tool.

Christian Herzog, CEO Dimensions, said: “There is an ever growing publication haystack and researchers need to find the needles of information quickly and efficiently. In the past you needed to know what to ask the search engine in order to find it, but with Dimensions L&C, we are now providing next generation discoverability for life sciences and chemistry researchers: an ontology driven retrieval engine which identifies relationships and links in more than 120m publications – allowing the researcher to move on from search to AI-supported discovery.”

Dimensions is used by scientists, academic institutions, funders and industry. Its database offers the most comprehensive collection of linked data in a single platform; from grants, publications, datasets and clinical trials to patents and policy documents. Because Dimensions maps the entire research lifecycle, research can be followed from funding through output to impact. It has transformed the way research is discovered, accessed and evaluated.

Digital Science is a technology company working to make research more efficient. We invest in, nurture and support innovative businesses and technologies that make all parts of the research process more open and effective. Our portfolio includes admired brands such as Altmetric, Dimensions, Figshare, ReadCube Papers, Symplectic, IFI CLAIMS, Overleaf, Ripeta, Scismic and Writefull. Digital Science’s Consultancy group works with organisations around the world to create new insights based on data to support decision makers. We believe that together, we can help researchers make a difference. Visit www.digital-science.com and follow @digitalsci on Twitter.

Dimensions is a modern, innovative, linked-research-knowledge system that re-imagines discovery and access to research. Developed by Digital Science in collaboration with over 100 research organizations around the world, Dimensions brings together grants, publications, citations, alternative metrics, clinical trials, patents and datasets to deliver a platform that enables users to find and access the most relevant information faster, analyze the academic and broader outcomes of research, and gather insights to inform future strategy.

Previous Post

Zydus receives EUA from DCGI for ZyCoV-D, the only needle-free COVID vaccine in the world

Next Post

Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia

Related Posts

SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Next Post
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia

Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In